Can Wegovy Drop Your Blood Sugar — and Should You Be Concerned?

You've just started Wegovy and you're wondering if that dizzy spell was your blood sugar dropping

This is one of the questions our prescribers hear regularly, and it's a reasonable one. Wegovy works by mimicking GLP-1, a hormone released after eating. GLP-1 tells the pancreas to release insulin, but crucially, it does this only when blood glucose is already above normal. That built-in mechanism is one reason hypoglycaemia (dangerously low blood sugar) is not a common feature of semaglutide in people who are otherwise healthy.

The dizziness, fatigue or nausea you feel in the first few weeks of treatment is far more likely to be gastrointestinal in origin. Nausea, queasiness and reduced appetite are the most frequently reported early side effects as your body adjusts. These usually settle over days to a couple of weeks. That said, reduced food intake does mean some people eat significantly less, and if you were already managing blood sugar with other medicines, a drop in glucose remains possible. Context is everything. The semaglutide overview covers the broader pharmacology if you want the full picture.

If your symptoms include shaking, cold sweats or confusion (particularly if they ease after eating something sweet) that pattern is worth flagging to a clinician the same day rather than waiting for a routine call.

Does Wegovy drop blood sugar in people with type 2 diabetes?

Yes, and this is where the evidence is clearest. Semaglutide was originally developed as a diabetes medicine before the 2.4mg dose was licensed under the Wegovy brand for weight management. In people living with type 2 diabetes, it lowers HbA1c (the three-month blood sugar average) meaningfully alongside its effect on body weight, and our dedicated page on semaglutide and blood sugar goes into the detail of how those effects work. The NHS notes this dual action on its semaglutide medicines page.

If you have type 2 diabetes and are already taking a sulphonylurea (such as gliclazide) or insulin, those medicines independently push blood sugar down regardless of whether glucose is high. Adding semaglutide into that mix raises the probability of blood glucose falling further than intended. The standard clinical response is to reduce the dose of the other agent, something your prescriber should plan for before you start, not after your first low reading.

It is worth knowing that Ozempic, which is also semaglutide, is licensed specifically for type 2 diabetes management. Wegovy carries its own licence for weight management. The two should not be conflated; how Wegovy specifically affects blood sugar is covered in its own dedicated page if you want to compare.

The Wegovy blood sugar drop: what signs actually need urgent attention

Mild fluctuations in how you feel day to day are common on any new medicine. The signs that point to genuine hypoglycaemia are more specific: shaking or trembling, rapid heartbeat, sweating when you're not warm, sudden hunger, difficulty concentrating, pale skin, and in more serious cases, confusion or slurred speech. If several of these appear together, particularly if eating something sugary resolves them within 15 minutes, that is a pattern worth discussing with a clinician, or calling 111 if symptoms don't ease.

The January 2026 MHRA Drug Safety Update for GLP-1 medicines focused primarily on pancreatitis (severe, persistent stomach pain that may radiate to the back), but it also reinforced that any unexpected or concerning symptom while on these medicines should be reported. You can flag suspected side effects directly at the MHRA Yellow Card scheme. That reporting genuinely helps regulators build a clearer picture of how these medicines behave in real-world use.

For anyone on diabetes medication, keeping a simple glucose diary in the first few weeks of Wegovy treatment is a practical step, checking before meals and before bed costs a couple of minutes and gives your prescriber something concrete to work with at your first review.

Who this matters most for, and how to raise it at your consultation

If you do not have diabetes and are not on any blood-sugar-lowering medicines, your risk of a meaningful Wegovy blood sugar drop is low. The glucose-dependent mechanism described above means the medicine tends not to push glucose below the normal range on its own. For most people starting Wegovy for weight management, reduced calorie intake (not semaglutide itself) is the more likely culprit if energy levels dip.

The picture shifts if you have prediabetes, insulin resistance or a family history of diabetes, or if you're taking any medicines that affect glucose. These are exactly the things a prescriber needs to know before treatment begins, which is why eligibility assessment covers far more than a BMI number. Wondering about the cost side of private treatment? The Wegovy pricing context page lays out what a transparent private prescription typically includes. Those who are new to Wegovy altogether may find it helpful to read the Wegovy overview for a full grounding before returning to blood sugar specifics.

Picking up a prescription before the school run used to mean a trip to the GP and then the chemist. The process for accessing Wegovy privately is more straightforward now, but if you've seen Wegovy ads and want to know whether the clinical rigour matches the marketing, the answer is that a named prescriber reads your answers, not software, and the conversation about medicines you already take happens before anything is dispensed. If you'd like that review, check your eligibility and our clinical team will take it from there.